Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Merih, Reis Aras"'
Autor:
Selim Sayın, Murat Yıldırım, Ahmet Kürşad Güneş, Merih Reis Aras, Esra Şafak Yılmaz, Murat Albayrak, Gülsüm Özet, Meltem Aylı
Publikováno v:
Gülhane Tıp Dergisi, Vol 66, Iss 1, Pp 43-48 (2024)
Aims:Lactate dehydrogenase (LDH) and platelet count are routinely used to evaluate response to treatment and discontinuation of treatment in thrombotic thrombocytopenic purpura (TTP). This study aimed to evaluate the mean platelet volume (MPV) and pl
Externí odkaz:
https://doaj.org/article/47de30a897a3422aa8f0b5b92140a89f
Does Systemic Immune Inflammation Index Predicts Survival In Diffuse Large B Cell Lymphoma Patients?
Autor:
Murat Albayrak, Ahmet Kürşad Güneş, Ümit Yavuz Malkan, Fatma Yılmaz, Hacer Berna Afacan Öztürk, Merih Reis Aras
Publikováno v:
Hitit Medical Journal, Vol 5, Iss 3, Pp 170-174 (2023)
Objective: The systemic immune inflammation index has been considered a novel prognostic biomarker in several malignant tumors. The aim of the current study was to determine the association between the systemic immune inflammation index and prognosis
Externí odkaz:
https://doaj.org/article/43b61cf9e6c64bdd9fe4f329215e5537
Autor:
İstemi Serin, Mehmet Hilmi Doğu, Ömer Ekinci, Gülsüm Akgün Çağlıyan, Abdulkadir Baştürk, Merih Reis Aras, Sinan Demircioğlu, Burhan Turgut, Mustafa Merter, Sibel Kabukçu Hacıoğlu, Metin Bağcı, Murat Albayrak, Serdal Korkmaz, Mehmet Ali Erkurt, Mehmet Sinan Dal, Fadime Ersoy Dursun, Anıl Tombak, İsmet Aydoğdu, Turgay Ulaş, Fevzi Altuntaş
Publikováno v:
İstanbul Medical Journal, Vol 24, Iss 2, Pp 120-125 (2023)
Introduction:Ruxolitinib is a small -molecule inhibitor of the JAK1/2 pathway. This study aimed to reveal the results and side-effect profile of the use of ruxolitinib as a treatment option in polycythemia vera (PV).Methods:A total of 34 patients wit
Externí odkaz:
https://doaj.org/article/2f9813f1062246cfa7c5bb2a592ed5f8
Autor:
Fatma YILMAZ, Murat ALBAYRAK, Abdulkerim YILDIZ, Hacer Berna AFACAN ÖZTÜRK, Senem MARAL, Ümit Yavuz MALKAN, Pınar AKYOL, Merih REİS ARAS, Buğra SAĞLAM, Mesut TIĞLIOĞLU
Publikováno v:
Ahi Evran Medical Journal, Vol 6, Iss 3, Pp 226-233 (2022)
Purpose: Coronavirus disease 2019 is a viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clinical and laboratory predictors may provide identification of patients at risk of mortality and guide treatment. This stud
Externí odkaz:
https://doaj.org/article/f82dcc849f63442a9e24b15068368e13
Autor:
Ümit Yavuz Malkan, Senem Maral, Fatma Yılmaz, Merih Reis Aras, Buğra Sağlam, Mesut Tığlıoğlu, Hacer Berna Afacan Öztürk, Murat Albayrak, Pınar Tığlıoğlu
Publikováno v:
Sağlık Akademisi Kastamonu, Vol 7, Iss Covid-19 Ek Sayısı, Pp 108-115 (2022)
Introduction Coronavirus disease 2019 (COVID-19) were declared as pandemic by World Health Organization. With this study, we aimed to define our patients who were followed up with malign or benign hematological diagnoses and diagnosed with COVID-19;
Externí odkaz:
https://doaj.org/article/64f1fa33e75d4cfebafd3c5791864f38
Autor:
Mesut Tığlıoğlu, Buğra Sağlam, Merih Reis Aras, Pınar Akyol, Senem Maral, Fatma Yılmaz, Hacer Berna Afacan Öztürk, Abdulkerim Yıldız, Murat Albayrak
Publikováno v:
Sağlık Akademisi Kastamonu, Vol 7, Iss Covid-19 Ek Sayısı, Pp 100-107 (2022)
Introduction Predictive parameters that can affect the course of this infection have been the main topic of research since the beginning of the COVID-19 (Coronavirus disease 2019) pandemic. Since the discovery of blood groups, the effect of these on
Externí odkaz:
https://doaj.org/article/606ddb9f24b1461880f055798a900a4f
Autor:
Buğra Sağlam, Murat Albayrak, Abdulkerim Yıldız, Pınar Tıplıoğlu, Mesut Tığlıoğlu, Merih Reis Aras, Fatma Yılmaz, Hacer Berna Afacan Öztürk
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 44, Iss , Pp S31- (2022)
Objective: Cancer is a well-known condition associated with its treatment and follow-up and increases the risk of thrombosis. As with solid tumors, the risk of venous thromboembolism (VTE) is quite high in lymphomas, especially high-grade B-cell lymp
Externí odkaz:
https://doaj.org/article/589349447bfe4dd798509635f0959170
Autor:
Umit Yavuz Malkan, Murat Albayrak, Hacer Berna Ozturk, Merih Reis Aras, Bugra Saglam, Kutsal Dogan
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 3, Pp 1368-1372 (2020)
Microangiopathic hemolytic anemia (MAHA) can be observed as a paraneoplastic syndrome (PS) in certain tumors. MAHA-related signet ring cell carcinoma (SRCC) of an unknown origin is very infrequent. Herein we present a SRCC case presented with refract
Externí odkaz:
https://doaj.org/article/40e70f08bd0b4df78380d2c11306a4cb
Autor:
Senem Maral, Murat Albayrak, Berna Afacan Öztürk, Ünsal Han, Merih Reis Aras, Gülten Korkmaz, Simten Dagdas, Aynur Albayrak, Gülsüm Özet
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S17- (2021)
Objective: Autologous hematopoetic stem cell transplantation (aHSCT) after high dose chemotherapy is a standard treatment for multiple myeloma (MM) patients. The successful aHSCT depends on collection of sufficient numbers of hematopoietic progenitor
Externí odkaz:
https://doaj.org/article/8fa8c444a7b34afba6e5cafc7670057e
Autor:
Fatma YILMAZ, Murat ALBAYRAK, Hacer Berna AFACAN ÖZTÜRK, Senem MARAL, Ümit Yavuz MALKAN, Pınar AKYOL, Merih REİS ARAS, Buğra SAĞLAM, Mesut TIĞLIOĞLU, Abdülkerim YILDIZ
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S19-S20 (2021)
Objective: Coronavirus disease 2019 is an infectious disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clinical and laboratory predictors may identification of patients at risk of mortality and guide treatment
Externí odkaz:
https://doaj.org/article/6666b030eae34e7dbaa3bbe3e3171e62